Search research articles
Contact Us
Filters
Showing results (1-10 of 91) with videos related to
Page
of 10
Sort By:
Parasite Immunology
|
August 21, 2009
The development of the RTS,S malaria vaccine candidate: challenges and lessons
W R Ballou
The Journal of Infectious Diseases
|
February 15, 2001
Vaccination utilizing the FimCH complex as a strategy to prevent Escherichia coli urinary tract infections
S Langermann, W R Ballou
Current Opinion in Infectious Diseases
|
October 13, 2006
Malaria in 1998: advances in diagnosis, drugs and vaccine development
D G Heppner, W R Ballou
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|
November 21, 2007
The current status of malaria vaccines
J A Stoute, W R Ballou
Progress in Allergy
|
January 1, 1988
Sporozoite immunity and vaccine development
W T Hockmeyer, W R Ballou
Parasitology Today (Personal Ed.)
|
October 17, 2006
Reply from stoute et Al
J Stoute, W R Ballou, U Krzych
The American Journal of Tropical Medicine and Hygiene
|
November 1, 1990
Immune response to Plasmodium berghei sporozoite antigens. I. Evaluation of murine T cell repertoire following immunization with irradiated sporozoites
H T Link, W R Ballou, U Krzych
Journal of Immunology (Baltimore, Md. : 1950)
|
September 1, 1989
Interactions of Plasmodium berghei sporozoites and murine Kupffer cells in vitro
M C Seguin, W R Ballou, C A Nacy
Microbial Pathogenesis
|
April 1, 1987
Developing a human malaria sporozoite vaccine
J F Young, W R Ballou, W T Hockmeyer
Progress in Clinical Parasitology
|
January 1, 1993
Antibodies to the circumsporozoite protein and protective immunity to malaria sporozoites
T R Jones, W R Ballou, S L Hoffman
Page
of 10
Search research articles
Search
Showing results (1-10 of 91) with videos related to
Sort By:
Page
of 10
Parasite Immunology
|
August 21, 2009
The development of the RTS,S malaria vaccine candidate: challenges and lessons
W R Ballou
The Journal of Infectious Diseases
|
February 15, 2001
Vaccination utilizing the FimCH complex as a strategy to prevent Escherichia coli urinary tract infections
S Langermann, W R Ballou
Current Opinion in Infectious Diseases
|
October 13, 2006
Malaria in 1998: advances in diagnosis, drugs and vaccine development
D G Heppner, W R Ballou
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|
November 21, 2007
The current status of malaria vaccines
J A Stoute, W R Ballou
Progress in Allergy
|
January 1, 1988
Sporozoite immunity and vaccine development
W T Hockmeyer, W R Ballou
Parasitology Today (Personal Ed.)
|
October 17, 2006
Reply from stoute et Al
J Stoute, W R Ballou, U Krzych
The American Journal of Tropical Medicine and Hygiene
|
November 1, 1990
Immune response to Plasmodium berghei sporozoite antigens. I. Evaluation of murine T cell repertoire following immunization with irradiated sporozoites
H T Link, W R Ballou, U Krzych
Journal of Immunology (Baltimore, Md. : 1950)
|
September 1, 1989
Interactions of Plasmodium berghei sporozoites and murine Kupffer cells in vitro
M C Seguin, W R Ballou, C A Nacy
Microbial Pathogenesis
|
April 1, 1987
Developing a human malaria sporozoite vaccine
J F Young, W R Ballou, W T Hockmeyer
Progress in Clinical Parasitology
|
January 1, 1993
Antibodies to the circumsporozoite protein and protective immunity to malaria sporozoites
T R Jones, W R Ballou, S L Hoffman
Page
of 10